Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study

NCT00006126 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Withdrawn
Start date
September 30, 1999
Completion date
April 30, 2001
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, kidney cancer, lung cancer, melanoma (skin), testicular germ cell tumor